You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 4, April 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Epidemiology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Articles for Residents
 •Macular Degeneration
 •Aging/ Geriatrics
 •Alert me on articles by topic

Prevalence of Age-Related Maculopathy in Older Europeans

The European Eye Study (EUREYE)

Cristina A. Augood, MD; Johannes R. Vingerling, MD; Paulus T. V. M. de Jong, MD, PhD; Usha Chakravarthy, MD, PhD; Johan Seland, MD; Gisele Soubrane, MD, PhD; Laura Tomazzoli, MD; Fotis Topouzis, MD, PhD; Graham Bentham, PhD; Mati Rahu, MD, PhD; Jesus Vioque, PhD; Ian S. Young, MBBS, PhD; Astrid E. Fletcher, PhD

Arch Ophthalmol. 2006;124:529-535.

Objective  To estimate the prevalence of age-related maculopathy in an older population from 7 European countries.

Methods  Randomly sampled people 65 years and older were invited to an eye examination in centers across 7 European countries (Norway, Estonia, United Kingdom, France, Italy, Greece, and Spain). Fundus images of each eye were graded at a single reading center. Prevalence rates were calculated for stage of age-related maculopathy with 95% confidence intervals (CIs) estimated for clustered data.

Results  Of 5040 participants (45% response rate), 4753 (2128 men and 2625 women) had gradable fundus images. The prevalences were grade 0, 47.59% (95% CI, 43.53%-51.65%); grade 1, 36.48% (95% CI, 32.66%-40.30%); grade 2, 10.14% (95% CI, 8.92% to 11.37%); grade 3, 2.46% (95% CI, 1.79%-3.13%); and grade 4 (age-related macular degeneration [AMD]), 3.32% (95% CI, 2.52%-4.13%) and large drusen only (≥125 µm), 15.41% (95% CI, 13.61%-17.21%). The prevalence of geographic atrophic AMD was 1.2% (95% CI, 0.8%-1.7%) and of neovascular AMD, 2.3% (95% CI, 1.7%-2.9%). The prevalence of bilateral AMD was 1.4% (95% CI, 1.0%-1.8%).

Conclusion  Age-specific prevalences of age-related maculopathy in the European Eye Study (EUREYE) are similar to other population-based studies in Western populations.


Author Affiliations: Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, England (Drs Augood and Fletcher); Departments of Ophthalmology (Dr Vingerling) and Epidemiology and Biostatistics (Drs Vingerling and de Jong), Erasmus Medical Centre, Rotterdam, and The Netherlands Ophthalmic Research Institute, KNAW, Department of Ophthalmology, Academic Medical Center, Amsterdam (Dr de Jong), the Netherlands; Department of Ophthalmology (Dr Chakravarthy) and Centre for Clinical and Population Sciences (Dr Young), Queen's University of Belfast, Belfast, Northern Ireland, UK; Øyeavdelingen, Haukeland Sykehus University of Bergen, Bergen, Norway (Dr Seland); Clinique Ophtalmologique, Universitaire De Creteil, Paris, France (Dr Soubrane); Clinica Oculistica, Università degli Studi di Verona, Verona, Italy (Dr Tomazzoli); "B" Department of Ophthalmology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece (Dr Topouzis); Centre for Environmental Risk, University of East Anglia, Norwich, England (Dr Bentham); Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia (Dr Rahu); Departamento de Salud Publica Universidad Miguel Hernandez, Alicante, Spain (Dr Vioque).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High-Resolution Spectral Domain-OCT Imaging in Geographic Atrophy Associated with Age-Related Macular Degeneration
Fleckenstein et al.
IOVS 2008;49:4137-4144.
ABSTRACT | FULL TEXT  

Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration
Augood et al.
Am. J. Clin. Nutr. 2008;88:398-406.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
Jager et al.
NEJM 2008;358:2606-2617.
FULL TEXT  

Investigating the Burden of Wet Macular Degeneration
Mitchell
Arch Ophthalmol 2007;125:1266-1268.
FULL TEXT  

Predictive Value of Multiple Genetic Testing for Age-Related Macular Degeneration
Despriet et al.
Arch Ophthalmol 2007;125:1270-1271.
FULL TEXT  

A view on new drugs for macular degeneration
DTB 2007;45:49-52.
FULL TEXT  

Histological evidence for revascularisation of an autologous retinal pigment epithelium-choroid graft in the pig
Maaijwee et al.
Br. J. Ophthalmol. 2007;91:546-550.
ABSTRACT | FULL TEXT  

Prevalence of Early and Late Age-Related Macular Degeneration in a Rural Population in Northern India: The INDEYE Feasibility Study
Gupta et al.
IOVS 2007;48:1007-1011.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.